⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,734.19
−1.44%
FTSE ADX
9,588.41
−1.17%
TASI
9,695.86
−2.32%
QE Index
8,611.10
−0.37%
S&P 500
7,629.40
−0.44%
Nasdaq 100
29,038.20
+0.27%
Nifty 50
22,600.00
−0.39%
Sensex
73,123.83
−0.17%
KSE-100
162,374.88
−0.95%
DFM:EMIRATESNBD
AED 30.00
−3.47%
ADX:IHC
AED 350.00
−0.57%
SAU:2222
SAR 25.40
−0.70%
DSMD:QNBK
QAR 15.50
−1.02%
NAS:NVDA
$211.91
−0.14%
NYSE:TSM
$416.96
+1.12%
NSE:RELIANCE
₹1,190.00
+0.46%
KAR:OGDC
Rs 298.12
−0.79%
Gold
$3,992.52
−0.80%
Brent
$116.26
+2.98%
BTC
$81,701.94
+0.48%
ETH
$2,409.11
+0.96%
DFM General
5,734.19
−1.44%
FTSE ADX
9,588.41
−1.17%
TASI
9,695.86
−2.32%
QE Index
8,611.10
−0.37%
S&P 500
7,629.40
−0.44%
Nasdaq 100
29,038.20
+0.27%
Nifty 50
22,600.00
−0.39%
Sensex
73,123.83
−0.17%
KSE-100
162,374.88
−0.95%
DFM:EMIRATESNBD
AED 30.00
−3.47%
ADX:IHC
AED 350.00
−0.57%
SAU:2222
SAR 25.40
−0.70%
DSMD:QNBK
QAR 15.50
−1.02%
NAS:NVDA
$211.91
−0.14%
NYSE:TSM
$416.96
+1.12%
NSE:RELIANCE
₹1,190.00
+0.46%
KAR:OGDC
Rs 298.12
−0.79%
Gold
$3,992.52
−0.80%
Brent
$116.26
+2.98%
BTC
$81,701.94
+0.48%
ETH
$2,409.11
+0.96%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NYSE
› RCUS
A
Arcus Biosciences Inc
NYSE:RCUS
Healthcare
CBOEFTSE:MRUT
NASDAQ:NQUSSG
$18.88
−2.48%
Live
In session · ≈
AED 69.34
· Market cap
$2.4B
· Next earnings
Tue 27 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
Arcus Biosciences Inc · News · TradingHolo
RCUS news
Headlines tagged to this company
DO
Arcus Shares Fall After Offering Priced
Dow Jones Newswires · 31 h ago
SE
Arcus Biosciences prices $250M public offering at $17.50 per share
Seeking Alpha · 32 h ago
DO
Arcus Biosciences: Granted Underwriters 30-Day Option to Purchase Up to 2.1M Additional Shares of Its Common Stock at Public Offering Price >RCUS
Dow Jones Newswires · 2 d ago
DO
Arcus Biosciences: Gross Proceeds From Offering Expected to Be $250.0M >RCUS
Dow Jones Newswires · 2 d ago
DO
Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock
Dow Jones Newswires · 2 d ago
DO
Arcus Biosciences Prices Underwritten Public Offering of 14.3M Shares at $17.50 Per Share>RCUS
Dow Jones Newswires · 2 d ago
DO
Arcus Biosciences: Offering Expected to Close Oct. 23 >RCUS
Dow Jones Newswires · 2 d ago
TR
Arcus Biosciences, Inc. (RCUS) Prices $250M Equity Offering
TradingView · 2 d ago
PR
Kuehn Law Encourages Investors of Arcus Biosciences, Inc. to Contact Law Firm
PR Newswire · 2 d ago
SE
Arcus Biosciences announces public stock offering
Seeking Alpha · 2 d ago
BU
Arcus Biosciences Announces Commencement of Public Offering of Common Stock
BusinessWire · 2 d ago
TR
Arcus Biosciences, Inc. (RCUS) Launches Public Stock Offering
TradingView · 2 d ago
DO
Arcus Biosciences Is Maintained at Buy by Citigroup
Dow Jones Newswires · 2 d ago
DO
Arcus Biosciences Price Target Raised to $41.00/Share From $40.00 by Truist Securities
Dow Jones Newswires · 2 d ago
TR
Truist Securities maintains Buy rating on Arcus Biosciences, $41 price target
TradingView · 2 d ago
DO
Arcus Biosciences Price Target Raised to $49.00/Share From $43.00 by Wedbush
Dow Jones Newswires · 2 d ago
TR
Wedbush maintains Outperform rating on Arcus Biosciences, $49 price target
TradingView · 2 d ago
QU
RCUS: Casdatifan’s development plan spans RCC lines, built on durable HIF-2 inhibition
Quartr · 3 d ago
More news →